Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2016 (2016), Article ID 4058580, 9 pages
http://dx.doi.org/10.1155/2016/4058580
Research Article

Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study

1Department of Neurology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD Delft, Netherlands
2Department of Psychiatry, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, Netherlands
3Department of Clinical Neurophysiology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, Netherlands
4Department of Neurology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, Netherlands

Received 14 September 2015; Revised 4 December 2015; Accepted 9 December 2015

Academic Editor: Yong-An Chung

Copyright © 2016 Angela E. P. Bouwmans et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Dubois and B. Pillon, “Cognitive deficits in Parkinson's disease,” Journal of Neurology, vol. 244, no. 1, pp. 2–8, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Caballol, M. J. Martí, and E. Tolosa, “Cognitive dysfunction and dementia in Parkinson disease,” Movement Disorders, vol. 22, supplement 17, pp. S358–S366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Emre, “Dementia associated with Parkinson's disease,” Lancet Neurology, vol. 2, no. 4, pp. 229–237, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Aarsland and M. W. Kurz, “The epidemiology of dementia associated with Parkinson's disease,” Brain Pathology, vol. 20, no. 3, pp. 633–639, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. N. Caviness, E. Driver-Dunckley, D. J. Connor et al., “Defining mild cognitive impairment in Parkinson's disease,” Movement Disorders, vol. 22, no. 9, pp. 1272–1277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. H. Williams-Gray, T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker, “Evolution of cognitive dysfunction in an incident Parkinson's disease cohort,” Brain, vol. 130, no. 7, pp. 1787–1798, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Janvin, D. Aarsland, J. P. Larsen, and K. Hugdahl, “Neuropsychological profile of patients with Parkinson's disease without dementia,” Dementia and Geriatric Cognitive Disorders, vol. 15, no. 3, pp. 126–131, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. T. C. Buter, A. van den Hout, F. E. Matthews, J. P. Larsen, C. Brayne, and D. Aarsland, “Dementia and survival in Parkinson disease: a 12-year population study,” Neurology, vol. 70, no. 13, pp. 1017–1022, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Hely, W. G. J. Reid, M. A. Adena, G. M. Halliday, and J. G. L. Morris, “The Sydney Multicenter Study of Parkinson's disease: the inevitability of dementia at 20 years,” Movement Disorders, vol. 23, no. 6, pp. 837–844, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Riedel, J. Klotsche, A. Spottke et al., “Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease,” Journal of Neurology, vol. 257, no. 7, pp. 1073–1082, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. G. W. Duncan, T. K. Khoo, A. J. Yarnall et al., “Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms,” Movement Disorders, vol. 29, no. 2, pp. 195–202, 2014. View at Publisher · View at Google Scholar
  12. P. Martinez-Martin, “The importance of non-motor disturbances to quality of life in Parkinson's disease,” Journal of the Neurological Sciences, vol. 310, no. 1-2, pp. 12–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. A. Hughes, H. F. Ross, R. H. S. Mindham, and E. G. S. Spokes, “Mortality in Parkinson's disease and its association with dementia and depression,” Acta Neurologica Scandinavica, vol. 110, no. 2, pp. 118–123, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Morley, S. Dummett, M. Peters et al., “Factors influencing quality of life in caregivers of people with Parkinson's disease and implications for clinical guidelines,” Parkinson's Disease, vol. 2012, Article ID 190901, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Berg and A. Gaenslen, “Place value of transcranial sonography in early diagnosis of Parkinson's disease,” Neurodegenerative Diseases, vol. 7, no. 5, pp. 291–299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. E. P. Bouwmans, A. M. M. Vlaar, K. Srulijes, W. H. Mess, and W. E. J. Weber, “Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical Parkinsonian syndromes,” International Review of Neurobiology, vol. 90, pp. 121–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Liepelt, A. Wendt, K. J. Schweitzer et al., “Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population,” Journal of Neural Transmission, vol. 115, no. 7, pp. 993–999, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Panza, V. Frisardi, C. Capurso et al., “Late-life depression, mild cognitive impairment, and dementia: possible continuum?” The American Journal of Geriatric Psychiatry, vol. 18, no. 2, pp. 98–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Monastero, F. Mangialasche, C. Camarda, S. Ercolani, and R. Camarda, “A systematic review of neuropsychiatric symptoms in mild cognitive impairment,” Journal of Alzheimer's Disease, vol. 18, no. 1, pp. 11–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. P. Hermida, W. M. McDonald, K. Steenland, and A. Levey, “The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?” Expert Review of Neurotherapeutics, vol. 12, no. 11, pp. 1339–1350, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. F. A. Wollenweber, R. Schomburg, M. Probst et al., “Width of the third ventricle assessed by transcranial sonography can monitor brain atrophy in a time- and cost-effective manner—results from a longitudinal study on 500 subjects,” Psychiatry Research: Neuroimaging, vol. 191, no. 3, pp. 212–216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Slansky, K. Herholz, U. Pietrzyk et al., “Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism,” Neuroradiology, vol. 37, no. 4, pp. 270–277, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. D. G. M. Murphy, C. D. DeCarli, E. Daly et al., “Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity,” Biological Psychiatry, vol. 34, no. 9, pp. 612–621, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. L. G. Apostolova, A. E. Green, S. Babakchanian et al., “Hippocampal atrophy and ventricular enlargement in normal aging, Mild Cognitive Impairment (MCI), and Alzheimer disease,” Alzheimer Disease & Associated Disorders, vol. 26, no. 1, pp. 17–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Ibarretxe-Bilbao, C. Junque, M. J. Marti, and E. Tolosa, “Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease,” Journal of the Neurological Sciences, vol. 310, no. 1-2, pp. 70–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. T. R. Melzer, R. Watts, M. R. MacAskill et al., “Grey matter atrophy in cognitively impaired Parkinson's disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 83, no. 2, pp. 188–194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. J. Burton, I. G. McKeith, D. J. Burn, E. D. Williams, and J. T. O'Brien, “Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls,” Brain, vol. 127, no. 4, pp. 791–800, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Camicioli, J. Sabino, M. Gee et al., “Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia,” Movement Disorders, vol. 26, no. 8, pp. 1443–1450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. T. O. Dalaker, R. Zivadinov, D. P. Ramasamy et al., “Ventricular enlargement and mild cognitive impairment in early Parkinson's disease,” Movement Disorders, vol. 26, no. 2, pp. 297–301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. M. M. Vlaar, A. E. P. Bouwmans, M. J. P. G. van Kroonenburgh et al., “Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms,” BMC Neurology, vol. 7, article 28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. A. M. M. Vlaar, T. de Nijs, M. J. P. G. Van Kroonenburgh et al., “The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans,” BMC Neurology, vol. 8, article 42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. A. E. P. Bouwmans, A. M. M. Vlaar, W. H. Mess, A. Kessels, and W. E. J. Weber, “Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients,” BMJ Open, vol. 3, no. 4, Article ID e002613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Dubois, D. Burn, C. Goetz et al., “Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force,” Movement Disorders, vol. 22, no. 16, pp. 2314–2324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Schrag, P. Barone, R. G. Brown et al., “Depression rating scales in Parkinson's disease: critique and recommendations,” Movement Disorders, vol. 22, no. 8, pp. 1077–1092, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. A. F. G. Leentjens, F. R. J. Verhey, R. Lousberg, H. Spitsbergen, and F. W. Wilmink, “The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease,” International Journal of Geriatric Psychiatry, vol. 15, no. 7, pp. 644–649, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease, “The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations,” Movement Disorders, vol. 18, no. 7, pp. 738–750, 2003. View at Google Scholar
  37. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 3, pp. 181–184, 1992. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Gilman, G. K. Wenning, P. A. Low et al., “Second consensus statement on the diagnosis of multiple system atrophy,” Neurology, vol. 71, no. 9, pp. 670–676, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Litvan, Y. Agid, D. Calne et al., “Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop,” Neurology, vol. 47, no. 1, pp. 1–9, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. I. G. McKeith, D. W. Dickson, J. Lowe et al., “Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium,” Neurology, vol. 65, no. 12, pp. 1863–1872, 2005. View at Google Scholar
  41. I. Litvan, D. A. Grimes, A. E. Lang et al., “Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration,” Journal of Neurology, vol. 246, supplement 2, pp. II1–II5, 1999. View at Google Scholar
  42. G. Deuschl, P. Bain, and M. Brin, “Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee,” Movement Disorders, vol. 13, supplement 3, pp. 2–23, 1998. View at Google Scholar
  43. A. Gironell and J. Kulisevsky, “Diagnosis and management of essential tremor and dystonic tremor,” Therapeutic Advances in Neurological Disorders, vol. 2, no. 4, pp. 215–222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. P. G. Glass, A. J. Lees, A. Bacellar, J. Zijlmans, R. Katzenschlager, and L. Silveira-Moriyama, “The clinical features of pathologically confirmed vascular Parkinsonism,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 83, no. 10, pp. 1027–1029, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker, “The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN Study,” Brain, vol. 127, no. 3, pp. 550–560, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. U. Walter, D. Dressler, A. Wolters, M. Wittstock, B. Greim, and R. Benecke, “Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia,” Journal of Neurology, vol. 253, no. 4, pp. 448–454, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. U. Walter, D. Dressler, A. Wolters, T. Probst, A. Grossmann, and R. Benecke, “Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy,” Neurology, vol. 63, no. 3, pp. 504–509, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. U. Walter, C. Klein, R. Hilker, R. Benecke, P. P. Pramstaller, and D. Dressler, “Brain parenchyma sonography detects preclinical parkinsonism,” Movement Disorders, vol. 19, no. 12, pp. 1445–1449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Berg, W. Roggendorf, U. Schröder et al., “Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury,” Archives of Neurology, vol. 59, no. 6, pp. 999–1005, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. U. Walter, “Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no,” Journal of Neural Transmission, vol. 118, no. 4, pp. 607–612, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Hagenah, I. R. König, J. Sperner et al., “Life-long increase of substantia nigra hyperechogenicity in transcranial sonography,” NeuroImage, vol. 51, no. 1, pp. 28–32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Behnke, K. L. Double, S. Duma et al., “Substantia nigra echomorphology in the healthy very old: correlation with motor slowing,” NeuroImage, vol. 34, no. 3, pp. 1054–1059, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Becker, M. Struck, U. Bogdahn, and T. Becker, “Echogenicity of the brainstem raphe in patients with major depression,” Psychiatry Research: Neuroimaging, vol. 55, no. 2, pp. 75–84, 1994. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Becker, T. Becker, M. Struck et al., “Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study,” Biological Psychiatry, vol. 38, no. 3, pp. 180–184, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. U. Walter, L. Prudente-Morrissey, S. C. Herpertz, R. Benecke, and J. Hoeppner, “Relationship of brainstem raphe echogenicity and clinical findings in depressive states,” Psychiatry Research—Neuroimaging, vol. 155, no. 1, pp. 67–73, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Andrade and S. Haj-Dahmane, “Serotonin neuron diversity in the dorsal raphe,” ACS Chemical Neuroscience, vol. 4, no. 1, pp. 22–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Gasbarri and A. Pompili, “Serotonergic 5-HT7 receptors and cognition,” Reviews in the Neurosciences, vol. 25, no. 3, pp. 311–323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. A. V. Terry Jr., J. J. Buccafusco, and C. Wilson, “Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets,” Behavioural Brain Research, vol. 195, no. 1, pp. 30–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. L. C. Silbert, J. F. Quinn, M. M. Moore et al., “Changes in premorbid brain volume predict Alzheimer's disease pathology,” Neurology, vol. 61, no. 4, pp. 487–492, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Weintraub, N. Dietz, J. E. Duda et al., “Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease,” Brain, vol. 135, part 1, pp. 170–180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. N. Pavese, “PET studies in Parkinson's disease motor and cognitive dysfunction,” Parkinsonism and Related Disorders, vol. 18, supplement 1, pp. S96–S99, 2012. View at Google Scholar · View at Scopus
  62. P. Jokinen, N. Scheinin, S. Aalto et al., “[11C]PIB-, [18F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia,” Parkinsonism & Related Disorders, vol. 16, no. 10, pp. 666–670, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. J. G. Goldman, C. Williams-Gray, R. A. Barker, J. E. Duda, and J. E. Galvin, “The spectrum of cognitive impairment in Lewy body diseases,” Movement Disorders, vol. 29, no. 5, pp. 608–621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. C. H. Williams-Gray, S. L. Mason, J. R. Evans et al., “The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 11, pp. 1258–1264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. D. Muslimović, B. Schmand, J. D. Speelman, and R. J. de Haan, “Course of cognitive decline in Parkinson's disease: a meta-analysis,” Journal of the International Neuropsychological Society, vol. 13, no. 6, pp. 920–932, 2007. View at Google Scholar
  66. D. Garcia-Garcia, P. Clavero, C. G. Salas et al., “Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 39, no. 11, pp. 1767–1777, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Donaghy, A. J. Thomas, and J. T. O'Brien, “Amyloid PET imaging in Lewy body disorders,” American Journal of Geriatric Psychiatry, vol. 23, no. 1, pp. 23–37, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Buongiorno, Y. Compta, and M. J. Martí, “Amyloid-β and τ biomarkers in Parkinson's disease-dementia,” Journal of the Neurological Sciences, vol. 310, no. 1-2, pp. 25–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Apaydin, J. E. Ahlskog, J. E. Parisi, B. F. Boeve, and D. W. Dickson, “Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response,” Archives of Neurology, vol. 59, no. 1, pp. 102–112, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. J. E. Duda, “Pathology and neurotransmitter abnormalities of dementia with Lewy bodies,” Dementia and Geriatric Cognitive Disorders, vol. 17, supplement 1, pp. 3–14, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. R. Hilker, A. V. Thomas, J. C. Klein et al., “Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways,” Neurology, vol. 65, no. 11, pp. 1716–1722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Huang, P. Mattis, K. Perrine, N. Brown, V. Dhawan, and D. Eidelberg, “Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease,” Neurology, vol. 70, no. 16, part 2, pp. 1470–1477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. P. M. Meyer, K. Strecker, K. Kendziorra et al., “Reduced α4β2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease,” Archives of General Psychiatry, vol. 66, no. 8, pp. 866–877, 2009. View at Publisher · View at Google Scholar · View at Scopus